PRTC

PureTech Health plc

20.00 USD

Last updated Dec 4, 20:28 UTC

Yesterday HIGH

$19.9

Yesterday LOW

$19

52w HIGH

$38.9

52w LOW

$17.85

EPS

-0.09

PE

-222.22

Next Earnings

Apr 26, 2024

Overview News Government Trades

PureTech Health plc stock is up 0.2% since 30 days ago. The next earnings date is Apr 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November.

PureTech Health plc discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease. It also provides hematopoietic stem cell based therapies for patients with blood cancer.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

puretechhealth.com

Benzinga Newsdesk

Mon Dec 19, 2022

PureTech's LYT-300 Demonstrates Oral Bioavailability, Tolerability And GABAA Receptor Target Engagement In Healthy Volunteers

Orally administered LYT-300 achieved blood levels of allopregnanolone at or above those associated with therapeutic effect.1 Allopregnanolone is a natural neurosteroid with proven efficacy that is currently only
Vuk Zdinjak

Wed Nov 30, 2022

PureTech Announces New Therapeutic Candidate LYT-310, An Oral CBD Prodrug

PureTech Health plc (NASDAQ: PRTC) (LSE:PRTC) announced the nomination of a new therapeutic candidate, LYT-310, which is an oral CBD prodrug and the second therapeutic candidate developed from PureTech’s Glyph platform to be advanced
Benzinga Insights

Mon Oct 17, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers
Charles Gross

Tue Oct 11, 2022

Nektar Announced That It Has Mutually Agreed With Puretech to Terminate Discussions Regarding a Potential Business Combination

Further to the announcement made by PureTech Health plc ("PureTech") on 7 October 2022, Nektar announces that it has mutually agreed with PureTech to terminate discussions regarding a potential business combination.
Lisa Levin

Mon Oct 10, 2022

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Lisa Levin

Fri Oct 7, 2022

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Vandana Singh

Fri Oct 7, 2022

PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
Lisa Levin

Fri Oct 7, 2022

Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session.
Benzinga Insights

Fri Oct 7, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Akanda (NASDAQ:AKAN) stock rose 27.1% to $0.52 during Friday's pre-market session. The company's market cap stands at $16.0 million.
Lisa Levin

Fri Oct 7, 2022

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.